NCT07475572 A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07388550 Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) Status NOT_YET_RECRUITING Phase PHASE1
NCT07122687 IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT06643117 Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) Status TERMINATED Phase PHASE3
NCT06551064 Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06472583 Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer Status RECRUITING Phase PHASE2
NCT06400160 Clinical Trial of TB511 in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06348199 A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05986331 Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma Status UNKNOWN Phase PHASE3
NCT05849480 A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC) Status RECRUITING Phase PHASE1/PHASE2
NCT05739006 Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies Status UNKNOWN Phase PHASE1
NCT04798781 Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT04627012 Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT02842125 Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02635672 Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01822652 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN Status ACTIVE_NOT_RECRUITING Phase PHASE1